BIN2
Bridging integrator 2
Also known as: BIN2_HUMAN, BRAP-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBW5
- Gene
- BIN2
- Ensembl
- ENSG00000110934
- Chromosome
- 12
- Canonical length
- 565 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables phospholipid binding activity. Involved in several processes, including phagocytosis, engulfment; plasma membrane tubulation; and podosome assembly. Located in phagocytic cup and podosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
565 residues, UniProt reviewed canonical sequence.
>Q9UBW5|BIN2
1 MAEGKAGGAA GLFAKQVQKK FSRAQEKVLQ KLGKAVETKD ERFEQSASNF YQQQAEGHKL
61 YKDLKNFLSA VKVMHESSKR VSETLQEIYS SEWDGHEELK AIVWNNDLLW EDYEEKLADQ
121 AVRTMEIYVA QFSEIKERIA KRGRKLVDYD SARHHLEAVQ NAKKKDEAKT AKAEEEFNKA
181 QTVFEDLNQE LLEELPILYN SRIGCYVTIF QNISNLRDVF YREMSKLNHN LYEVMSKLEK
241 QHSNKVFVVK GLSSSSRRSL VISPPVRTAT VSSPLTSPTS PSTLSLKSES ESVSATEDLA
301 PDAAQGEDNS EIKELLEEEE IEKEGSEASS SEEDEPLPAC NGPAQAQPSP TTERAKSQEE
361 VLPSSTTPSP GGALSPSGQP SSSATEVVLR TRTASEGSEQ PKKRASIQRT SAPPSRPPPP
421 RATASPRPSS GNIPSSPTAS GGGSPTSPRA SLGTGTASPR TSLEVSPNPE PPEKPVRTPE
481 AKENENIHNQ NPEELCTSPT LMTSQVASEP GEAKKMEDKE KDNKLISANS SEGQDQLQVS
541 MVPENNNLTA PEPQEEVSTS ENPQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BIN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 96 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 96 nTPM
- spleen: 49 nTPM
- thymus: 45 nTPM
- lymph node: 39 nTPM
- tonsil: 34 nTPM
- appendix: 31 nTPM
Single-cell type
- platelets: 1,233 nCPM
- neutrophils: 548 nCPM
- megakaryocytes: 532 nCPM
- neutrophil progenitors: 390 nCPM
- nk-cells: 339 nCPM
- extravillous trophoblasts: 293 nCPM
Immune cell
- basophil: 666 nTPM
- total PBMC: 479 nTPM
- non-classical monocyte: 414 nTPM
- neutrophil: 381 nTPM
- intermediate monocyte: 312 nTPM
- gdT-cell: 282 nTPM
Brain region
- thalamus: 10 nTPM
- white matter: 9.5 nTPM
- medulla oblongata: 8.5 nTPM
- pons: 7.2 nTPM
- midbrain: 5.8 nTPM
- spinal cord: 5.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.06
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Amphiphysin
- BAR domain
- AH/BAR domain superfamily
- BAR domain
- Bridging integrator 2, BAR domain
- Bridging integrator 2, C-terminal tail
- Bridging integrator 2, C-terminal tail
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BIN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BIN2 as an antibody target. Whether an autoantibody or antibody against BIN2 could matter depends on whether native BIN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BIN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BIN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...